Cargando…
Endocrinology in the time of COVID-19: Management of pituitary tumours
Patients with pituitary tumours, ensuing hormonal abnormalities and mass effects are usually followed in multidisciplinary pituitary clinics and can represent a management challenge even during the times of non-pandemic. The COVID-19 pandemic has put on hold routine medical care for hundreds of mill...
Autores principales: | Fleseriu, Maria, Dekkers, Olaf M, Karavitaki, Niki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7938006/ https://www.ncbi.nlm.nih.gov/pubmed/32369770 http://dx.doi.org/10.1530/EJE-20-0473 |
Ejemplares similares
-
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing's syndrome
por: Newell-Price, John, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of hyperthyroidism and hypothyroidism
por: Boelaert, Kristien, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of adrenal insufficiency
por: Arlt, Wiebke, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of thyroid nodules and cancer
por: Vrachimis, Alexis, et al.
Publicado: (2020) -
ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia
por: Christ-Crain, Mirjam, et al.
Publicado: (2020)